Human Papillomavirus (HPV) is the most common sexually transmitted infection globally, affecting millions each year. It is a major cause of several types of cancers, notably cervical cancer, which remains a leading cause of cancer-related death among women in many parts of the world. This comprehensive guide explores the types of HPV that pose the greatest risk, discusses the critical importance of the HPV vaccine, and reviews the latest advancements in screening and treatment options.
The Risk and Types of HPV
HPV includes more than 100 different viruses, with about 14 considered high-risk for leading to cancer. HPV types 16 and 18 are particularly notorious, responsible for approximately 70% of cervical cancer cases worldwide. These types can cause persistent infections, which may lead to cell changes in the cervix if not properly managed.
Importance of the HPV Vaccine
The introduction of the HPV vaccine has marked a significant advancement in public health, offering protection against the most dangerous strains of the virus. Recommended for preteens of all genders, the vaccine is most effective when administered before individuals become sexually active. Extending its availability up to age 45, recent guidelines offer a chance for a broader demographic to receive the vaccine, providing a second chance for those who missed initial vaccinations.
Advances in Screening and Treatment
Early detection of HPV-related changes remains crucial. Regular screening through Pap smears and HPV tests is recommended for women starting at age 21, contributing significantly to decreasing rates of cervical cancer. For those who test positive for high-risk HPV, follow-up procedures might include colposcopy or a biopsy. Treatment varies based on the findings but can include methods such as cryotherapy, conization, and, in more advanced cases, appropriate cancer treatments.
For more information or to book your consultation, please contact The London Gynaecologist here.